Advanced Cancer Therapeutics: Strategies and Technologies for Targeted Drug Delivery explores the heterogeneity of tumors and microenvironmental factors that influence cancer treatment and contribute to drug resistance. The book discusses critical elements such as tumor stroma, vasculature, pH, hypoxia, and enzymatic activity that impact therapeutic efficacy. Sections cover advanced drug formulations, including supramolecular systems, metal-organic frameworks, and nanomedicine, focusing on their roles in selective drug delivery for early detection, diagnosis, and treatment of various cancers. In addition, it reviews the current status and future perspectives of these formulations, highlighting their potential to enhance therapeutic outcomes while minimizing side effects.
Readers will also find discussions on the limitations of nanocarriers, along with regulatory and ethical considerations related to anticancer formulations. This resource is invaluable for researchers, clinicians, and students, offering insights into the latest advancements in drug delivery systems.
"synopsis" may belong to another edition of this title.
Dr. Kumar holds the position of Formulation Scientist and Deputy Manager in Research and Development, Cadila Pharmaceutical Limited, Ahmedabad, Gujarat. He completed his doctoral degree at the Indian Institute of Technology (Banaras Hindu University), Varanasi-221005, India. He possesses 6 years of academic research experience. His specialization is Pharmaceutics, working on various drug delivery systems including controlled drug delivery systems, nanoemulsions, polymeric nanoparticles, lipid nanoparticles, nanocrystals, nanofibrous scaffolds, hydrogels, and microneedles for treating cancer, wounds, infections, and inflammatory disorders. To date, he has authored over 50 peer-reviewed articles and about 25 book chapters in well-known international journals. He has 4 patents in his name and edited 2 books. He is working continuously to drive forward cutting-edge research in nanomedicine and drug delivery technologies.
Dr. Jha is an Assistant Professor in the Department of Pharmaceutics at Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pune, Maharashtra, India. He has more than 8 years of professional experience in academic research, specializing in advanced drug delivery systems, cancer nanomedicine, and 3-D bioprinting. Holding a Ph.D. from the Indian Institute of Technology (BHU), Varanasi, his work focuses on developing targeted therapeutic interventions for cancer, inflammatory lung disorders, and chronic wounds. His research on modern therapeutics leverages deep expertise in extracellular vesicles, nanofibers, polymer chemistry, and microneedle technology. So far, he has contributed to 3 patents, more than 50 peer-reviewed articles and 25 book chapters published in reputed international journals, and edited 2 books. As an academician, he views education as the art of assisting discovery; empowering students to harness their curiosity, transforming foundational concepts into tangible scientific impact.
Dr. Mishra is a Professor and former Head of the Department of Pharmaceutical Engineering & Technology at the Indian Institute of Technology (Banaras Hindu University). Having earned his B. Pharm, M. Pharm as a Gold Medalist, and Ph.D. from the same institution, he has dedicated over 42 years to advancing pharmaceutical sciences. Throughout his career, Prof. Mishra has established a profound commitment to academic guidance, mentoring over 100 postgraduates, doctoral, and post-doctorate candidates. His research focuses on multiple emulsions, nanomedicine, targeted and rate-controlled drug delivery systems, pharmacokinetics, and bioavailability. This work has yielded over 300 publications, 220 abstracts, 50 book chapters, and 5 patents. With more than 14,000 citations and an h-index exceeding 60, his scholarly impact places him in the top 5% of global researchers as per SciRank Global Database. Beyond his research, Prof. Mishra’s institutional leadership, policy contributions, and enduring dedication to his students continue to anchor and advance pharmaceutical education worldwide.He is a leading researcher in drug delivery. He has received numerous awards, including the Best Young Pharmacy Teacher Award and the Pharmacy Excellence Award. Additionally, he has served on editorial boards, traveled internationally for talks, and participated in various academic committees and programs.
Advanced Drug Delivery Systems for Targeted Cancer Therapy explores the heterogeneity of tumors and microenvironmental factors that influence cancer treatment and contribute to drug resistance. It discusses critical elements such as tumor stroma, vasculature, pH, hypoxia, and enzymatic activity that impact therapeutic efficacy. The book covers advanced drug formulations, including supramolecular systems, metal-organic frameworks, and nanomedicine, focusing on their roles in selective drug delivery for early detection, diagnosis, and treatment of various cancers. It reviews the current status and future perspectives of these formulations, highlighting their potential to enhance therapeutic outcomes while minimizing side effects. Additionally, it examines the limitations of nanocarriers and addresses regulatory and ethical considerations related to anticancer formulations. This resource is invaluable for researchers, clinicians, and students, offering insights into the latest advancements in drug delivery systems. It bridges the gap between conventional and innovative therapies, equipping the audience with essential knowledge for developing precise cancer treatment strategies.
"About this title" may belong to another edition of this title.
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Paperback. Condition: new. Paperback. Advanced Cancer Therapeutics Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9780443441851
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. 2026. 1st Edition. paperback. . . . . . Seller Inventory # V9780443441851
Seller: moluna, Greven, Germany
Condition: New. Presents an extensive examination of various advanced drug formulations, including nanomedicine, supramolecular systems, and metal-organic frameworks, highlighting their roles in targeted cancer therapyEmphasizes the significance of the tum. Seller Inventory # 2752639232
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 330 pages. 9.25x7.50x1.97 inches. In Stock. Seller Inventory # x-0443441855
Quantity: 2 available
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. 2026. 1st Edition. paperback. . . . . . Books ship from the US and Ireland. Seller Inventory # V9780443441851
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Neuware - Advanced Cancer Therapeutics: Strategies and Technologies for Targeted Drug Delivery explores the heterogeneity of tumors and microenvironmental factors that influence cancer treatment and contribute to drug resistance. The book discusses critical elements such as tumor stroma, vasculature, pH, hypoxia, and enzymatic activity that impact therapeutic efficacy. Sections cover advanced drug formulations, including supramolecular systems, metal-organic frameworks, and nanomedicine, focusing on their roles in selective drug delivery for early detection, diagnosis, and treatment of various cancers. In addition, it reviews the current status and future perspectives of these formulations, highlighting their potential to enhance therapeutic outcomes while minimizing side effects.Readers will also find discussions on the limitations of nanocarriers, along with regulatory and ethical considerations related to anticancer formulations. This resource is invaluable for researchers, clinicians, and students, offering insights into the latest advancements in drug delivery systems. Seller Inventory # 9780443441851